JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Dominique Shum-Tim
John E. Mayer, Jr.
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinoka, T.
Right arrow Articles by Mayer, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinoka, T.
Right arrow Articles by Mayer, J. E., Jr.

J Thorac Cardiovasc Surg 1998;115:536-546
© 1998 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering

Toshiharu Shinoka, MDa, Dominique Shum-Tim, MDa, Peter X. Ma, PhDb, Ronn E. Tanel, MDc, Noritaka Isogai, MDd, Robert Langer, PhDb, Joseph P. Vacanti, MDd, John E. Mayer, Jr., MDa

This work was supported by generous grants from the Department of Cardiac Surgery, Children's Hospital, Boston, Advanced Tissue Sciences, Inc., La Jolla, the Thomas Anthony Pappas Charitable Foundation, Inc., Boston and the Department of Surgery, Children's Hospital, Boston.

Read at the Seventy-seventh Annual Meeting of The American Association for Thoracic Surgery, Washington, D.C., May 4-7, 1997.

Received for publication May 6, 1997; accepted for publication Sept. 18, 1997. Address for reprints: John E. Mayer, Jr., MD, Department of Cardiovascular Surgery, Boston Children's Hospital, 300 Longwood Ave., Boston, MA 02115.

Background: "Repair" of many congenital cardiac defects requires the use of conduits to establish right ventricle to pulmonary artery continuity. At present, available homografts or prosthetic conduits lack growth potential and can become obstructed by tissue ingrowth or calcification leading to the need for multiple conduit replacements. Tissue engineering is an approach by which cells are grown in vitro onto biodegradable polymers to construct "tissues" for implantation. A tissue engineering approach has recently been used to construct living cardiac valve leaflets from autologous cells in our laboratory. This study assesses the feasibility of a tissue engineering approach to constructing tissue-engineered "living" pulmonary artery conduits.
Materials and methods: Ovine artery (group A, n = 4) or vein (group V, n = 3) segments were harvested, separated into individual cells, expanded in tissue culture, and seeded onto synthetic biodegradable (polyglactin/polyglycolic acid) tubular scaffolds (20 mm long x 15 mm diameter). After 7 days of in vitro culture, the autologous cell/polymer vascular constructs were used to replace a 2 cm segment of pulmonary artery in lambs (age 68.4 ± 15.5 days, weight 18.7 ± 2.0 kg). One other control animal received an acellular polymer tube sealed with fibrin glue without autologous cells. Animals were sacrificed at intervals of 11 to 24 weeks (mean follow-up 130.3 ± 30.8 days, mean weight 38.9 ± 13.0 kg) after echocardiographic and angiographic studies. Explanted tissue-engineered conduits were assayed for collagen (4-hydroxyproline) and calcium content, and a tissue deoxyribonucleic acid assay (bis-benzimide dye) was used to estimate number of cell nuclei as an index of tissue maturity.
Results: The acellular control graft developed progressive obstruction and thrombosis. All seven tissue-engineered grafts were patent and demonstrated a nonaneurysmal increase in diameter (group A = 18.3 ± 1.3 mm = 95.3% of native pulmonary artery; group V = 17.1 ± 1.2 mm = 86.8% of native pulmonary artery). Histologically, none of the biodegradable polymer scaffold remained in any tissue-engineered graft by 11 weeks. Collagen content in tissue-engineered grafts was 73.9% ± 8.0% of adjacent native pulmonary artery. Histologically, elastic fibers were present in the media layer of tissue-engineered vessel wall and endothelial specific factor VIII was identified on the luminal surface. Deoxyribonucleic acid assay showed a progressive decrease in numbers of cell nuclei over 11 and 24 weeks, suggesting an ongoing tissue remodeling. Calcium content of tissue-engineered grafts was elevated (group A = 7.95 ± 5.09; group V = 13.2 ± 5.48; native pulmonary artery = 1.2 ± 0.8 mg/gm dry weight), but no macroscopic calcification was found.
Conclusions: Living vascular grafts engineered from autologous cells and biodegradable polymers functioned well in the pulmonary circulation as a pulmonary artery replacement. They demonstrated an increase in diameter suggesting growth and development of endothelial lining and extracellular matrix, including collagen and elastic fibers. This tissue-engineering approach may ultimately allow the development of viable autologous vascular grafts for clinical use.




This article has been cited by other articles:


Home page
 Asian Cardiovasc. Thorac. Ann.Home page
G. Furlanetto, C. H Passerino, R. Siegel, D. T Chueng, S. Levitsky, and I. S J Casagrande
Biointegration and Growth of Porcine Valved Pulmonary Conduits in a Sheep Model
Asian Cardiovasc Thorac Ann, August 1, 2009; 17(4): 350 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. A. Mettler, V. L. Sales, C. L. Stucken, V. Anttila, K. Mendelson, J. Bischoff, and J. E. Mayer Jr
Stem Cell-Derived, Tissue-Engineered Pulmonary Artery Augmentation Patches In Vivo
Ann. Thorac. Surg., July 1, 2008; 86(1): 132 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
D. Schmidt, U. A Stock, and S. P Hoerstrup
Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices
Phil Trans R Soc B, August 29, 2007; 362(1484): 1505 - 1512.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. P. Hoerstrup, I. Cummings MRCS, M. Lachat, F. J. Schoen, R. Jenni, S. Leschka, S. Neuenschwander, D. Schmidt, A. Mol, C. Gunter, et al.
Functional Growth in Tissue-Engineered Living, Vascular Grafts: Follow-Up at 100 Weeks in a Large Animal Model
Circulation, July 4, 2006; 114(1_suppl): I-159 - I-166.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. G. Leyh, M. Wilhelmi, P. Rebe, S. Ciboutari, A. Haverich, and H. Mertsching
Tissue Engineering of Viable Pulmonary Arteries for Surgical Correction of Congenital Heart Defects
Ann. Thorac. Surg., April 1, 2006; 81(4): 1466 - 1471.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Iwai, Y. Sawa, S. Taketani, K. Torikai, K. Hirakawa, and H. Matsuda
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall
Ann. Thorac. Surg., November 1, 2005; 80(5): 1821 - 1827.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. H.L. Tang, S. Fazel, R. D. Weisel, G. S. Van Arsdell, and R.-K. Li
Cardiovascular Tissue Engineering Therapy: So Near, So Far?
Ann. Thorac. Surg., June 1, 2005; 79(6): 1831 - 1833.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Shin'oka, G. Matsumura, N. Hibino, Y. Naito, M. Watanabe, T. Konuma, T. Sakamoto, M. Nagatsu, and H. Kurosawa
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells
J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1330 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
N. Hibino, T. Shin'oka, G. Matsumura, Y. Ikada, and H. Kurosawa
The tissue-engineered vascular graft using bone marrow without culture
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1064 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Swartz, J. A. Russell, and S. T. Andreadis
Engineering of fibrin-based functional and implantable small-diameter blood vessels
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1451 - H1460.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Iwai, Y. Sawa, H. Ichikawa, S. Taketani, E. Uchimura, G. Chen, M. Hara, J. Miyake, and H. Matsuda
Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 472 - 479.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Opitz, K. Schenke-Layland, T. U Cohnert, B. Starcher, K. J. Halbhuber, D. P Martin, and U. A Stock
Tissue engineering of aortic tissue: dire consequence of suboptimal elastic fiber synthesis in vivo
Cardiovasc Res, September 1, 2004; 63(4): 719 - 730.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. R. Lee, H. G. Lim, Y. J. Kim, J. R. Rho, E. J. Bae, C. I. Noh, Y. S. Yun, and C. Ahn
Repair of transposition of the great arteries, ventricular septal defect and left ventricular outflow tract obstruction
Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 735 - 741.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. J. Koh and A. Atala
Tissue Engineering, Stem Cells, and Cloning: Opportunities for Regenerative Medicine
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1113 - 1125.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Kadner, G. Zund, C. Maurus, C. Breymann, S. Yakarisik, G. Kadner, M. Turina, and S. P. Hoerstrup
Human umbilical cord cells for cardiovascular tissue engineering: a comparative study
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 635 - 641.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Walles, H. Gorler, C. Puschmann, and H. Mertsching
Functional neointima characterization of vascular prostheses in human
Ann. Thorac. Surg., March 1, 2004; 77(3): 864 - 868.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. Rieder, M.-T. Kasimir, G. Silberhumer, G. Seebacher, E. Wolner, P. Simon, and G. Weigel
Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 399 - 405.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Schenke-Layland, F. Opitz, M. Gross, C. Doring, K.J. Halbhuber, F. Schirrmeister, Th. Wahlers, and U.A. Stock
Complete dynamic repopulation of decellularized heart valves by application of defined physical signals--an in vitro study
Cardiovasc Res, December 1, 2003; 60(3): 497 - 509.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Matsumura, S. Miyagawa-Tomita, T. Shin'oka, Y. Ikada, and H. Kurosawa
First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In Vivo
Circulation, October 7, 2003; 108(14): 1729 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. M. Nugent and E. R. Edelman
Tissue Engineering Therapy for Cardiovascular Disease
Circ. Res., May 30, 2003; 92(10): 1068 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. G. Leyh, M. Wilhelmi, P. Rebe, S. Fischer, T. Kofidis, A. Haverich, and H. Mertsching
In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation
Ann. Thorac. Surg., May 1, 2003; 75(5): 1457 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. Naito, Y. Imai, T. Shin'oka, J. Kashiwagi, M. Aoki, M. Watanabe, G. Matsumura, Y. Kosaka, T. Konuma, N. Hibino, et al.
Successful clinical application of tissue-engineered graft for extracardiac Fontan operation
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 419 - 420.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Ozawa, D. A. G. Mickle, R. D. Weisel, N. Koyama, H. Wong, S. Ozawa, and R.-K. Li
Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats
J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1157 - 1164.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. C. Elkins
Tissue-engineered valves
Ann. Thorac. Surg., November 1, 2002; 74(5): 1434 - 1434.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Kadner, S. P. Hoerstrup, J. Tracy, C. Breymann, C. F. Maurus, S. Melnitchouk, G. Kadner, G. Zund, and M. Turina
Human umbilical cord cells: a new cell source for cardiovascular tissue engineering
Ann. Thorac. Surg., October 1, 2002; 74(4): S1422 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Cebotari, H. Mertsching, K. Kallenbach, S. Kostin, O. Repin, A. Batrinac, C. Kleczka, A. Ciubotaru, and A. Haverich
Construction of Autologous Human Heart Valves Based on an Acellular Allograft Matrix
Circulation, September 24, 2002; 106(12_suppl_1): I-63 - I-68.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. P. Hoerstrup, A. Kadner, C. Breymann, C. F. Maurus, C. I. Guenter, R. Sodian, J. F. Visjager, G. Zund, and M. I. Turina
Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells
Ann. Thorac. Surg., July 1, 2002; 74(1): 46 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Kadner, S. P. Hoerstrup, G. Zund, K. Eid, C. Maurus, S. Melnitchouk, J. Grunenfelder, and M. I. Turina
A new source for cardiovascular tissue engineering: human bone marrow stromal cells
Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 1055 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
Y. J. Kim, Y. S. Choi, J. R. Lee, and J. R. Rho
Ventricular Outflow Tract Reconstruction With Polystan Valved Conduit
Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 187 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. R. Fuchs, B. A. Nasseri, and J. P. Vacanti
Tissue engineering: a 21st century solution to surgical reconstruction
Ann. Thorac. Surg., August 1, 2001; 72(2): 577 - 591.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Sakai, R.-K. Li, R. D. Weisel, D. A. G. Mickle, E. T. J. Kim, Z.-Q. Jia, and T. M. Yau
The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat
J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 932 - 942.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Jockenhoevel, G. Zund, S. P. Hoerstrup, K. Chalabi, J. S. Sachweh, L. Demircan, B. J. Messmer, and M. Turina
Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering
Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 424 - 430.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. A. Folliguet, C. Rucker-Martin, C. Pavoine, E. Deroubaix, M. Henaff, J.-J. Mercadier, and S. N. Hatem
Adult cardiac myocytes survive and remain excitable during long-term culture on synthetic supports
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 510 - 519.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
T. Shin'oka, Y. Imai, and Y. Ikada
Transplantation of a Tissue-Engineered Pulmonary Artery
N. Engl. J. Med., February 15, 2001; 344(7): 532 - 533.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A.J. Levine, P.A. Miller, O.S. Stumper, J.G.C. Wright, E.D. Silove, J.V. De Giovanni, B. Sethia, and W.J. Brawn
Early results of right ventricular-pulmonary artery conduits in patients under 1 year of age
Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 122 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Della Rocca, S. Sartore, D. Guidolin, B. Bertiplaglia, G. Gerosa, D. Casarotto, and P. Pauletto
Cell composition of the human pulmonary valve: a comparative study with the aortic valve-the VESALIO* project
Ann. Thorac. Surg., November 1, 2000; 70(5): 1594 - 1600.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. Sodian, S. P. Hoerstrup, J. S. Sperling, S. H. Daebritz, D. P. Martin, F. J. Schoen, J. P. Vacanti, and J. E. Mayer Jr
Tissue engineering of heart valves: in vitro experiences
Ann. Thorac. Surg., July 1, 2000; 70(1): 140 - 144.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Homann, J. C. Haehnel, N. Mendler, S. U. Paek, K. Holper, H. Meisner, and R. Lange
Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts
Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 624 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Q. Ye, G. Zund, S. Jockenhoevel, S. P. Hoerstrup, A. Schoeberlein, J. Grunenfelder, and M. Turina
Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue
Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 449 - 454.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
U. A. Stock, M. Nagashima, P. N. Khalil, G. D. Nollert, T. Herden, J. S. Sperling, A. Moran, J. Lien, D. P. Martin, F. J. Schoen, et al.
TISSUE-ENGINEERED VALVED CONDUITS IN THE PULMONARY CIRCULATION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 732 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Shum-Tim, U. Stock, J. Hrkach, T. Shinoka, J. Lien, M. A. Moses, A. Stamp, G. Taylor, A. M. Moran, W. Landis, et al.
Tissue engineering of autologous aorta using a new biodegradable polymer
Ann. Thorac. Surg., December 1, 1999; 68(6): 2298 - 2304.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The American Association for Thoracic Surgery.